Aptitude Medical Systems

Aptitude is excited to sponsor the CalUCA annual conference in Irvine! Half of urgent care visits are for respiratory infectious diseases. Point-of-care molecular tests maximize clinical value and patient satisfaction by delivering definitive results to patients during the same visit. Unfortunately, traditional POC molecular tests are complicated, costly, and force providers into risky contracts - so they hurt your bottom line. Our Metrix? platform transforms molecular testing to provide the performance you'd expect without any of the downsides. Come visit our booth to learn how Metrix can help you unlock both better medicine and better margins!

Aptitude is attending the 1st SERUCA annual conference in Atlanta to introduce our breakthrough Metrix? molecular testing platform. We recently presented our platform and our value propositions to UCCs at the NERUCA annual conference with great reception. If you are a UCC operator looking to provide better medicine and improve your margins, please don’t hesitate to talk to our team at SERUCA to learn how we can help!

Aptitude is attending the 1st SERUCA annual conference in Atlanta to introduce our breakthrough Metrix? molecular testing platform. We recently presented our platform and our value propositions to UCCs at the NERUCA annual conference with great reception. If you are a UCC operator looking to provide better medicine and improve your margins, please don’t hesitate to talk to our team at SERUCA to learn how we can help!

Imagine a future where all common infectious diseases can be accurately diagnosed and treated without delay - how much anxiety and healthcare expense can be avoided? We developed the Metrix? molecular testing platform to provide the missing link for realizing that future. Metrix goes wherever accurate disease testing is needed, whether it’s in a pediatric office, an urgent care center, a pharmacy, or at home or office. We are exhibiting at HLTH (booth #5122) in Las Vegas next week - come talk to us to learn how Metrix can help improve infectious disease management in your organization! #HLTH

We developed the Metrix??molecular testing platform to empower distributed healthcare. Metrix helps every clinic provide rapid MDx on-site with no capital, no contract, and no training needed. It's a win-win for patients and clinics. We are on a whirlwind tour to introduce Metrix at the following meetings in the next two weeks: 1. NERUCA meeting in Connecticut #NERUCA #Urgentcare 2. AAFP FMX meeting in Pheonix?#AAFP #Familymedicine 3. AAP National Conference in Orlando #AAP #Pediatrics 4. Merchant Medicine Symposium in Nashville #Merchantmedicine #Urgentcare If you plan to?attend any of these meetings, please talk to us to learn how Metrix can help your practice provide better medicine with better margins!

Aptitude is excited to introduce our breakthrough Metrix? molecular testing platform at the Community Health Institute (CHI) & Expo in Atlanta. Community Health Centers (CHCs) are vital to health equity in America. Yet, CHCs face critical funding and staffing shortages that compromise their ability to deliver quality healthcare to over 30 million patients. Metrix empowers CHCs to improve health outcomes, patient experience, and operational efficiency. Metrix is the easiest-to-use MDx platform with no staff training or maintenance needed, and its disruptively simple design eliminates onerous cost structures. The upcoming Metrix Covid/Flu combo test (under FDA review) yields lab-accurate results: 3 diseases, 1 test, 20 minutes. Aptitude continues to democratize diagnostics so providers in CHCs and other distributed clinics can offer uncompromising care.

I can’t wait to show you Aptitude’s latest breakthroughs that deliver on our promise of democratizing diagnostics. Let’s connect at #ADLM2024!

Aptitude is excited to join the UCA Assembly in Miami this week to introduce our breakthrough Metrix? molecular testing platform. More than ever, Americans put their trust in Urgent Care Centers for healthcare. In turn, UCCs need to balance patient demand for rapid high-quality care, limited space and staff, and financial feasibility. Metrix empowers UCCs to give their patients the most reliable diagnostics and informed treatments in a single visit. The pocket-sized multiplex testing system is the simplest on the market so it can be run by anyone on the roster. By eliminating big instruments, Metrix eliminates the need for purchasing contracts so UCCs get the flexibility they need to provide better care with better margins.

Join Aptitude at ADLM in Chicago next week to learn how Aptitude is transforming point-of-care diagnostics with Metrix?. We get it - molecular testing has been limited by big instruments, complex workflows, and high costs, causing providers to compromise between better care and better margins. Metrix changes the game, offering rapid, high-performance testing that empowers healthcare providers to deliver reliable diagnostics and treatment in a single visit.? This pocket-sized multiplex testing system is the simplest on the market, so it can be run by anyone on the team and disrupts cost barriers eliminating the need for contracts.? No instruments. No contracts. No compromises. No brainer. Visit us at Booth 553 to learn more.

Aptitude is excited to join the UCA Assembly in Miami this week to introduce our breakthrough Metrix? molecular testing platform. More than ever, Americans put their trust in Urgent Care Centers for healthcare. In turn, UCCs need to balance patient demand for rapid high-quality care, limited space and staff, and financial feasibility. Metrix empowers UCCs to give their patients the most reliable diagnostics and informed treatments in a single visit. The pocket-sized multiplex testing system is the simplest on the market so it can be run by anyone on the roster. By eliminating big instruments, Metrix eliminates the need for purchasing contracts so UCCs get the flexibility they need to provide better care with better margins.